Manatuck Hill Partners’s Neuronetics STIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-920,000
Closed -$3.21M 143
2025
Q2
$3.21M Hold
920,000
1.21% 29
2025
Q1
$3.39M Buy
+920,000
New +$3.36M 1.56% 23
2021
Q1
Sell
-13,500
Closed -$150K 137
2020
Q4
$150K Hold
13,500
0.06% 96
2020
Q3
$66K Buy
+13,500
New +$51.2K 0.03% 94

Other funds holding STIM

Manatuck Hill Partners's STIM Position: Q3 2025 in Review

Manatuck Hill Partners sold out of Neuronetics (STIM) in Q3 2025, closing a stake of 920,000 shares — an estimated $3.21M sold.

Manatuck Hill Partners first reported a position in STIM in Q3 2020 and held it in 4 quarters. The position peaked at $3.39M in Q1 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q3 2025.

  • Manatuck Hill Partners reported no remaining Neuronetics position as of Q3 2025 after selling out during the quarter.
  • Manatuck Hill Partners sold 920,000 Neuronetics shares in Q3 2025, an estimated $3.21M.
  • Manatuck Hill Partners first reported a position in Neuronetics in Q3 2020 and held it in 4 quarters.
  • Manatuck Hill Partners's Neuronetics position peaked at $3.39M in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q3 2025.

Based on Manatuck Hill Partners's 13F filing for Q3 2025, filed 14 Nov 2025.